[HTML] lww.com

[HTML][HTML] Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study

AM Moon, S Cook, RM Swier, HK Sanoff… - Hepatology …, 2023 - journals.lww.com
Background: Patient-reported outcomes (PRO) measures relevant to domains most
important to patients with HCC who received locoregional therapies are needed to advance …
被引用次数：1 相关文章

Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study.

AM Moon, S Cook, RM Swier, HK Sanoff… - Hepatology …, 2023 - europepmc.org
Background Patient-reported outcomes (PRO) measures relevant to domains most important
to patients with HCC who received locoregional therapies are needed to advance patient …

Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study

AM Moon, S Cook, RM Swier… - Hepatology …, 2023 - utsouthwestern.elsevierpure.com
Background: Patient-reported outcomes (PRO) measures relevant to domains most
important to patients with HCC who received locoregional therapies are needed to advance …

Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study

AM Moon, S Cook, RM Swier… - Hepatology …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Patient-reported outcomes (PRO) measures relevant to domains most important
to patients with HCC who received locoregional therapies are needed to advance patient …
[HTML] nih.gov

[HTML][HTML] Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study

AM Moon, S Cook, RM Swier, HK Sanoff… - Hepatology …, 2023 - ncbi.nlm.nih.gov
Background: Patient-reported outcomes (PRO) measures relevant to domains most
important to patients with HCC who received locoregional therapies are needed to advance …
[HTML] lww.com

[HTML][HTML] Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study

AM Moon, S Cook, RM Swier, HK Sanoff… - Hepatology …, 2023 - journals.lww.com
Background: Patient-reported outcomes (PRO) measures relevant to domains most
important to patients with HCC who received locoregional therapies are needed to advance …